In Whose Best Interest? Breaching the Academic–Industrial Wall
Top Cited Papers
- 30 November 2000
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (22) , 1646-1649
- https://doi.org/10.1056/nejm200011303432213
Abstract
In 1799, Benjamin Waterhouse, one of the three full-time professors at Harvard Medical School, received a copy of Edward Jenner's Inquiry into the Causes and Effects of the Variolae Vaccinae. Armed with new knowledge of the efficacy of cowpox vaccination for the prevention of smallpox, Waterhouse proposed to test the vaccine in Boston and, if successful, to develop a monopoly under which he would inoculate New England children for a fee.1 After receiving the cowpox preparation from England, Waterhouse inoculated first his son Daniel, then six other members of his household. He next carried out a clinical study in which . . .Keywords
This publication has 9 references indexed in Scilit:
- A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical ResearchNew England Journal of Medicine, 2000
- Conflict-of-Interest Policies for Investigators in Clinical TrialsNew England Journal of Medicine, 2000
- Policies on Faculty Conflicts of Interest at US UniversitiesJAMA, 2000
- Assessing Faculty Financial Relationships With IndustryJAMA, 2000
- Protecting Research Subjects — What Must Be DoneNew England Journal of Medicine, 2000
- Uneasy Alliance — Clinical Investigators and the Pharmaceutical IndustryNew England Journal of Medicine, 2000
- Is Academic Medicine for Sale?New England Journal of Medicine, 2000
- Academia and industry: increasingly uneasy bedfellowsThe Lancet, 2000
- Benjamin Waterhouse and the Introduction of VaccinationPublished by University of Pennsylvania Press ,1957